Trexquant Investment LP Has $2.27 Million Stake in Nu Skin Enterprises, Inc. $NUS

Key Points

• Trexquant Investment LP has reduced its stake in Nu Skin Enterprises by 45.5%, bringing its total shares owned to 312,794, valued at approximately $2.27 million.
• Insider trading activity includes a sale of 6,489 shares by Director Laura Nathanson and 20,000 shares by EVP Chayce David Clark, reflecting a general trend of insider selling in the company.
• Financial analysts have upgraded Nu Skin's rating, with a consensus rating of "Hold" and a target price of $6.88, after the company reported better-than-expected earnings results.

Trexquant Investment LP cut its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 45.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 312,794 shares of the company's stock after selling 261,123 shares during the period. Trexquant Investment LP owned approximately 0.63% of Nu Skin Enterprises worth $2,271,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of NUS. Prescott Group Capital Management L.L.C. raised its position in Nu Skin Enterprises by 142.7% during the first quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company's stock valued at $10,125,000 after buying an additional 819,972 shares during the period. Pacer Advisors Inc. acquired a new position in Nu Skin Enterprises during the first quarter valued at $4,577,000. Two Sigma Advisers LP raised its position in Nu Skin Enterprises by 61.2% during the fourth quarter. Two Sigma Advisers LP now owns 944,000 shares of the company's stock valued at $6,504,000 after buying an additional 358,400 shares during the period. Charles Schwab Investment Management Inc. raised its position in Nu Skin Enterprises by 47.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company's stock valued at $7,640,000 after buying an additional 336,807 shares during the period. Finally, D. E. Shaw & Co. Inc. raised its position in Nu Skin Enterprises by 15.5% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock valued at $15,512,000 after buying an additional 301,295 shares during the period. 82.84% of the stock is owned by institutional investors and hedge funds.

Nu Skin Enterprises Stock Down 0.7%

NYSE NUS traded down $0.09 on Wednesday, reaching $11.52. The stock had a trading volume of 404,688 shares, compared to its average volume of 543,236. The business has a 50 day moving average price of $10.13 and a 200 day moving average price of $8.24. The company has a current ratio of 2.01, a quick ratio of 1.38 and a debt-to-equity ratio of 0.27. Nu Skin Enterprises, Inc. has a 1 year low of $5.32 and a 1 year high of $12.40. The company has a market capitalization of $569.99 million, a price-to-earnings ratio of 5.73 and a beta of 0.92.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.18. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%.The firm had revenue of $386.14 million for the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Shareholders of record on Friday, August 29th will be paid a $0.06 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.24 dividend on an annualized basis and a yield of 2.1%. Nu Skin Enterprises's payout ratio is 11.94%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Wall Street Zen lowered Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a research report on Friday, September 5th. Zacks Research raised Nu Skin Enterprises to a "hold" rating in a research report on Tuesday, August 12th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $6.88.

Insider Buying and Selling at Nu Skin Enterprises

In other news, EVP Chayce David Clark sold 20,000 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the transaction, the executive vice president owned 233,140 shares of the company's stock, valued at approximately $2,790,685.80. This represents a 7.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Laura Nathanson sold 6,489 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $12.22, for a total value of $79,295.58. Following the transaction, the director directly owned 33,149 shares in the company, valued at approximately $405,080.78. This represents a 16.37% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 58,926 shares of company stock worth $711,364 over the last 90 days. 2.00% of the stock is currently owned by corporate insiders.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.